In cutaneous melanoma, down-regulation of miR-29c has been associated with an adverse prognosis, attributed in part to its regulation of transcripts for the DNA methyltransferases DNMT3A/DNMT3B [73]. Here, DNMT3B is linked to cutaneous melanoma.